UK markets close in 6 hours 33 minutes

CytomX Therapeutics, Inc. (CTMX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.14-0.05 (-0.96%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
66,420
100,362
57,489
59,502
71,623
Operating expenses
Research development
94,528
112,936
131,619
103,866
92,277
Selling general and administrative
36,398
36,031
36,765
33,510
25,605
Total operating expenses
130,926
148,967
168,384
137,376
117,882
Operating income or loss
-64,506
-48,605
-110,895
-77,874
-46,259
Interest expense
-
-
0
-
-
Total other income/expenses net
-120
-27
-135
-68
-27
Income before tax
-64,208
-46,796
-102,665
-70,301
-43,612
Income tax expense
0
-13,911
-427
14,303
-513
Income from continuing operations
-64,208
-32,885
-102,238
-84,604
-43,099
Net income
-64,208
-32,885
-102,238
-84,604
-43,099
Net income available to common shareholders
-64,208
-32,885
-102,238
-84,604
-43,099
Basic EPS
-
-0.71
-2.26
-2.03
-1.16
Diluted EPS
-
-0.71
-2.26
-2.03
-1.16
Basic average shares
-
46,146
45,336
41,664
37,167
Diluted average shares
-
46,146
45,336
41,664
37,167
EBITDA
-
-46,032
-100,060
-75,990
-44,614